Rodrigues
TL3 Regular · Nuremberg, DE
Long-standing member. Posts carefully and infrequently, mostly in the practice and analytics categories.
Joined 5 December 2024 · last posted 1d
145 posts, newest first. Showing up to 150.
-
Splitting an overlong document into two Replied, post #35 · Documentation › Wiki requests · 27 Jul 2026 · 0 likes Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues, contrast problems, small text) report it. Accessibility matters.
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #69 · Compounds › Retatrutide · 17 Jul 2026 · 1 like Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is mechanistically plausible for benefit in metabolic liver disease. Whether that…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #109 · Devices › Syringes & needles · 17 Jul 2026 · 2 likes Reading units correctly: look at the marking from the side, not from above or below. The bottom of the plunger tip is the reading. Parallax error (wrong angle) is a…
-
What is genuinely unknown about long-term amylin agonism Replied, post #27 · Compounds › Cagrilintide & amylin analogues · 12 Jul 2026 · 22 likes post #26 is right about the mechanism and I think understates the practical bit. What is genuinely unknown about long-term amylin agonism: real-world response rates,…
-
How shortages have affected compounding permissions Replied, post #14 · Access › Shortages · 4 Jul 2026 · 7 likes I read post #12 twice before replying, because I had assumed the opposite. Communication from suppliers: a supplier having supply problems usually communicates them. If…
-
Immortal time bias in a claims-database study — one year on Replied, post #6 · Evidence › Study critique · 3 Jul 2026 · 0 likes Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you think that affects the conclusion, maybe your criticism is…
-
What is genuinely unknown about long-term amylin agonism Started this topic · Compounds › Cagrilintide & amylin analogues · 3 Jul 2026 · 40 likes What is genuinely unknown about long-term amylin agonism — that is the question, and I have not found it answered plainly anywhere I have looked. Comparing STEP 8 (…
-
Prescription requirements and telehealth models — a second dataset Replied, post #85 · Sourcing › Regulatory · 30 Jun 2026 · 1 like This follows post #82 rather than contradicting it. Why this category is maintained as documentation, not as recommendations: the goal is factual accuracy and sourcing,…
-
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #13 · Compounds › Cagrilintide & amylin analogues · 23 Jun 2026 · 23 likes On post #9 — agreed on the reasoning, with one qualification. Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined…
-
Micronutrient adequacy at low total intake Replied, post #16 · Nutrition & Training › Protein & intake · 7 Jun 2026 · 5 likes I read post #14 twice before replying, because I had assumed the opposite. Meeting protein targets on suppressed appetite: this is where the practical difficulty lies.…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #24 · Compounds › Secretagogues & GH axis · 5 Jun 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #44 · Sourcing › Red flags · 4 Jun 2026 · 17 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Naming conventions for research peptides and the confusion they cause Replied, post #11 · Compounds › Other compounds · 4 Jun 2026 · 25 likes Coming back to post #9, because the follow-up matters more than the original answer. When "no data" is the complete and final answer: if there is no published human…
-
Reading a trial's population section before its results Replied, post #85 · Evidence › Trials · 4 Jun 2026 · 9 likes The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate different things by using different handling rules for people…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #47 · Access › Insurance & coverage · 3 Jun 2026 · 0 likes Coming back to post #45, because the follow-up matters more than the original answer. Prior authorisation: pre-approval requirements and how to satisfy them. Most…
-
Reading a trial's population section before its results Replied, post #64 · Evidence › Trials · 29 May 2026 · 10 likes Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug. Per-protocol includes only those who completed it as…
-
Micro-titration: a disputed topic, argued properly Replied, post #81 · Practice › Dosing & titration · 29 May 2026 · 32 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #41 · Compounds › Semaglutide · 27 May 2026 · 2 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
Shakes versus food: a pragmatic assessment Replied, post #10 · Nutrition & Training › Protein & intake · 16 May 2026 · 29 likes Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the gastrointestinal effects of these compounds. High fibre on top of…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #23 · Pharmacology › Formulation chemistry · 15 May 2026 · 4 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #23 · Evidence › Trials · 11 May 2026 · 20 likes post #22 answers the question as asked. The question underneath it is different. Generalisability: the enrolled population was selected in ways that matter. Entry…
-
Why chargeback is not the safety net people assume Replied, post #13 · Sourcing › Payments · 11 May 2026 · 4 likes Coming back to post #11, because the follow-up matters more than the original answer. Cryptocurrency for payment: offers less fraud protection than credit cards and is…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #38 · Practice › Interactions · 5 May 2026 · 0 likes Worth separating two things that post #34 runs together. Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric…
-
Blind submission and why it changes minds — the long version Replied, post #55 · Sourcing › Independent verification · 3 May 2026 · 2 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
Reimbursement variation across member states Replied, post #3 · Regional › European Union · 1 May 2026 · 1 like Germany: BfArM implements EU framework. Statutory insurance (the majority) excludes "lifestyle medicines" including weight management. Private prescription is common.…
-
Micro-titration: a disputed topic, argued properly Replied, post #64 · Practice › Dosing & titration · 23 Apr 2026 · 27 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #53 · Devices › Syringes & needles · 23 Apr 2026 · 9 likes Aspirating before injection: for subcutaneous injection, aspirating (pulling back on the plunger to check for blood) is not necessary and is sometimes discouraged…
-
Coming back to: Time to steady state after a dose increase Replied, post #35 · Pharmacology › Pharmacokinetics · 18 Apr 2026 · 23 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
-
Choosing which test to pay for, given a fixed budget Replied, post #67 · Sourcing › Independent verification · 13 Apr 2026 · 7 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
Reading a home test result without over-claiming Replied, post #6 · Analytics › Home & field testing · 6 Apr 2026 · 0 likes Picking up post #3: that is the part I would want checked first. What you can use home tests for: confirmation that a solution contains peptide (as opposed to being…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #12 · Pharmacology › Formulation chemistry · 1 Apr 2026 · 26 likes post #11 is right about the mechanism and I think understates the practical bit. Amino acid residues and formulation: the specific sequence and composition of a peptide…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #73 · Practice › Storage & stability · 25 Mar 2026 · 30 likes On post #69 — agreed on the reasoning, with one qualification. Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based…
-
[2026 update] Buffers, pH and why a formulation is a formulation Replied, post #2 · Pharmacology › Formulation chemistry · 17 Mar 2026 · 0 likes Excipients and their purposes: mannitol, sucrose, or other sugars in lyophilised formulations protect the peptide during drying and storage. They are not impurities;…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #53 · Start Here › Welcome · 14 Mar 2026 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #15 · Analytics › Impurities & related substances · 11 Mar 2026 · 17 likes Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #50 · Research Methods › Statistics · 11 Mar 2026 · 2 likes I read post #48 twice before replying, because I had assumed the opposite. Relative risk and odds ratios: both compare the rate in one group to the rate in another.…
-
When a dose reduction is the correct response to a side effect — a second dataset Replied, post #8 · Practice › Dosing & titration · 8 Mar 2026 · 0 likes Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #42 · Practice › Interactions · 7 Mar 2026 · 3 likes On post #38 — agreed on the reasoning, with one qualification. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk.…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #69 · Compounds › Semaglutide · 19 Feb 2026 · 2 likes I read post #67 twice before replying, because I had assumed the opposite. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and…
-
Measurement error in home scales, with a worked standard deviation Replied, post #8 · Research Methods › Statistics · 16 Feb 2026 · 22 likes This follows post #5 rather than contradicting it. Power and sample size: a study might be too small to detect a real effect (low power). Sample size calculations help…
-
Second pass at: Identical chromatograms across two different lots Replied, post #9 · Sourcing › Red flags · 15 Feb 2026 · 26 likes Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #37 · Practice › Storage & stability · 10 Feb 2026 · 0 likes Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #15 · Practice › Interactions · 6 Feb 2026 · 1 like Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
-
Dead volume across syringe and needle combinations Replied, post #67 · Devices › Syringes & needles · 6 Feb 2026 · 13 likes Picking up post #64: that is the part I would want checked first. Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid,…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #80 · Access › Pricing · 4 Feb 2026 · 30 likes International pricing: the same compound costs very different amounts in different countries because healthcare systems and regulatory frameworks differ. Generally, US…
-
Coming back to: What the published dose-response for semaglutide actually looks like… Replied, post #8 · Compounds › Semaglutide · 2 Feb 2026 · 0 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
Dead volume across syringe and needle combinations Replied, post #56 · Devices › Syringes & needles · 17 Jan 2026 · 2 likes Reading units correctly: look at the marking from the side, not from above or below. The bottom of the plunger tip is the reading. Parallax error (wrong angle) is a…
-
Travelling with an injectable: documentation and practicalities Replied, post #6 · Access › International · 16 Jan 2026 · 4 likes Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
-
Adolescents: a distinct evidence base — one year on Replied, post #52 · Clinical › Special populations · 9 Jan 2026 · 0 likes Picking up post #49: that is the part I would want checked first. Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings…
-
Tracking that stops updating and then resumes Replied, post #63 · Sourcing › Logistics · 3 Jan 2026 · 12 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
How to read a phase 2 result without treating it as a phase 3 result Replied, post #31 · Compounds › Retatrutide · 22 Dec 2025 · 15 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
[2026 update] What a good consultation looks like from the other side Replied, post #7 · Clinical › Prescriber conversations · 13 Dec 2025 · 2 likes Discussing side effects: be specific. "Nausea" is less useful than "I have nausea worst 24 to 36 hours after injection, severity 2 to 3 out of 4, stable over weeks".…
-
Temperature loggers worth the money — the long version Replied, post #88 · Devices › Cold chain · 7 Dec 2025 · 19 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #14 · Meta › Site feedback · 6 Dec 2025 · 29 likes Display issues: broken layouts, images not loading, text overlapping — report with the browser and device you were using. Display bugs are platform-specific.
-
Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #2 · marked as the solution · Compounds › Tirzepatide · 4 Dec 2025 · 7 likes Coming back to the opening post, because the follow-up matters more than the original answer. Storage and stability: published data on licensed tirzepatide formulations…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #17 · Start Here › Welcome · 3 Dec 2025 · 0 likes Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #60 · Clinical › Special populations · 1 Dec 2025 · 1 like Coming back to post #58, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #21 · Outcomes › Body composition · 30 Nov 2025 · 0 likes I read post #19 twice before replying, because I had assumed the opposite. Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and…
-
Thyroid function tests during substantial weight change Replied, post #149 · Clinical › Bloodwork · 26 Nov 2025 · 22 likes Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change in creatinine might not mean a real change in kidney…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #26 · Analytics › Impurities & related substances · 19 Nov 2025 · 0 likes Coming back to post #24, because the follow-up matters more than the original answer. Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #76 · Start Here › How to Ask · 27 Oct 2025 · 6 likes Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which one holds. Do not open with "I think you are wrong". Lead with…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #71 · Compounds › Tirzepatide · 22 Oct 2025 · 2 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #93 · Devices › Cold chain · 21 Oct 2025 · 4 likes Travel with medication: carrying a vial across borders requires planning if temperatures will exceed the range or if journey time is long. Insulated travel cases with…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #6 · Compounds › Oral incretins · 14 Oct 2025 · 8 likes post #5 is right about the mechanism and I think understates the practical bit. Why an oral formulation is a formulation achievement: the molecule is the same but the…
-
Comparing my trajectory with the trial curves, carefully Replied, post #58 · Outcomes › Progress reports · 6 Oct 2025 · 6 likes post #57 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #43 · Compounds › Tirzepatide · 21 Sep 2025 · 11 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #59 · Sourcing › Vendor reports · 20 Sep 2025 · 21 likes What "verified" means on our pages: specific lots were independently measured on stated dates by named services and results were consistent with the supplier's…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #61 · Practice › Reconstitution · 16 Sep 2025 · 23 likes post #60 is right about the mechanism and I think understates the practical bit. Choosing a concentration on purpose rather than by accident: starting with "I want to…
-
A preprint whose numbers changed substantially at publication Replied, post #53 · Evidence › Preprints · 14 Sep 2025 · 28 likes Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #33 · Data & Tools › Datasets · 7 Sep 2025 · 29 likes Bias toward positive outcomes: datasets collected by members are biased toward people who found the compounds useful. People who did not respond do not return. People…
-
Hypertension improvement and when medication needs revisiting Replied, post #41 · Clinical › Comorbidities · 4 Sep 2025 · 21 likes Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without diabetes; SUSTAIN 6 was in high-risk diabetes. Absolute…
-
Titles that describe the question, not the situation Replied, post #85 · Start Here › How to Ask · 1 Sep 2025 · 3 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
-
A preprint whose numbers changed substantially at publication Replied, post #26 · Evidence › Preprints · 21 Aug 2025 · 0 likes Picking up post #23: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
An emergency department visit, described afterwards Replied, post #54 · Safety › Adverse events · 15 Aug 2025 · 19 likes Coming back to post #52, because the follow-up matters more than the original answer. Psychological adverse events: mood changes, anxiety, or suicidal ideation warrant…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #19 · Evidence › Journal club · 11 Aug 2025 · 10 likes I read post #17 twice before replying, because I had assumed the opposite. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #44 · Compounds › Retatrutide · 11 Aug 2025 · 10 likes I read post #42 twice before replying, because I had assumed the opposite. Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises…
-
Travel coolers and how long they really hold Replied, post #67 · Devices › Cold chain · 6 Aug 2025 · 32 likes Light protection: avoid direct sunlight and UV exposure. Amber vials or opaque containers reduce light exposure. For short-term storage, keeping the vial in its…
-
A request that was declined, and the reasoning — a second dataset Replied, post #6 · Documentation › Wiki requests · 5 Aug 2025 · 4 likes Correction requests: if you spot an error in a maintained page, note it here with the specific correction. The maintainer will review and update if justified.
-
How to research a compound with no human data without deceiving yourself Replied, post #85 · Compounds › Other compounds · 3 Aug 2025 · 4 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
-
How to research a compound with no human data without deceiving yourself Replied, post #64 · Compounds › Other compounds · 2 Aug 2025 · 5 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
-
EU-wide position versus national implementation Replied, post #22 · Regional › European Union · 1 Aug 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #45 · Compounds › Cagrilintide & amylin analogues · 10 Jul 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #84 · Compounds › Tirzepatide · 8 Jul 2025 · 18 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #22 · Documentation › Doc review · 7 Jul 2025 · 7 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
System suitability injections: if they failed, the run did not happen Replied, post #12 · Analytics › HPLC & UHPLC · 5 Jul 2025 · 0 likes Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #151 · Evidence › Journal club · 4 Jul 2025 · 0 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #3 · Analytics › COA interpretation · 2 Jul 2025 · 23 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Antibiotics and a course of something with delayed emptying Replied, post #72 · Practice › Interactions · 23 Jun 2025 · 0 likes On post #68 — agreed on the reasoning, with one qualification. Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class…
-
Meeting a protein target on a suppressed appetite Replied, post #6 · Nutrition & Training › Protein & intake · 22 Jun 2025 · 2 likes post #5 answers the question as asked. The question underneath it is different. Eating anything at all: on substantial appetite suppression, eating enough total…
-
A supplier that answers analytical questions with restated claims Replied, post #102 · Sourcing › Red flags · 22 Jun 2025 · 0 likes Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability.
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #45 · Compounds › Repair & healing peptides · 20 Jun 2025 · 16 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Distinguishing a deletion sequence by mass alone — the long version Replied, post #28 · Analytics › Mass spectrometry · 20 Jun 2025 · 0 likes I read post #26 twice before replying, because I had assumed the opposite. Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈…
-
Coming back to: Official shortage notices and what they authorise Replied, post #32 · Access › Shortages · 17 Jun 2025 · 11 likes I read post #30 twice before replying, because I had assumed the opposite. Allocation and rationing: during severe shortages, suppliers might ration allocation to…
-
Comparing my trajectory with the trial curves, carefully Replied, post #14 · Outcomes › Progress reports · 15 Jun 2025 · 9 likes post #13 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #88 · Compounds › Cagrilintide & amylin analogues · 13 Jun 2025 · 7 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #23 · Analytics › Home & field testing · 5 Jun 2025 · 23 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #61 · Compounds › Tirzepatide · 27 May 2025 · 0 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
-
Half-life, steady state, and accumulation worked through Replied, post #28 · Pharmacology › Pharmacokinetics · 27 May 2025 · 2 likes Fasting requirement for oral semaglutide: food and large fluid volumes reduce absorption. The fasting window (30 minutes before and 30 minutes after) is designed to…
-
UK access routes, dated and sourced — a second dataset Replied, post #80 · Regional › UK & Ireland · 20 May 2025 · 4 likes post #79 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Half-life, steady state, and accumulation worked through Replied, post #3 · Pharmacology › Pharmacokinetics · 19 May 2025 · 4 likes I read the opening post twice before replying, because I had assumed the opposite. Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days.…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #100 · Sourcing › Independent verification · 15 May 2025 · 0 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #78 · Practice › Interactions · 9 May 2025 · 0 likes post #77 is right about the mechanism and I think understates the practical bit. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #106 · Evidence › Journal club · 29 Apr 2025 · 6 likes Worth separating two things that post #102 runs together. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority…
-
A supplier that answers analytical questions with restated claims Replied, post #63 · Sourcing › Red flags · 24 Apr 2025 · 7 likes This follows post #60 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Reading order for a first week here, and what to skip until later Replied, post #93 · Start Here › Welcome · 21 Apr 2025 · 7 likes Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds.
-
Adjudicated events and why the definition matters — the long version Replied, post #108 · Evidence › Trials · 20 Apr 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Adjudicated events and why the definition matters — the long version Replied, post #95 · Evidence › Trials · 12 Apr 2025 · 3 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
A certificate with no method stated: what can you conclude? Replied, post #55 · Analytics › COA interpretation · 10 Apr 2025 · 27 likes post #54 is right about the mechanism and I think understates the practical bit. Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A…
-
A certificate with no method stated: what can you conclude? Replied, post #42 · Analytics › COA interpretation · 7 Apr 2025 · 1 like This follows post #39 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #52 · Sourcing › Vendor reports · 3 Apr 2025 · 0 likes Worth separating two things that post #48 runs together. Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years…
-
Review cadence: how often is a page actually re-checked? Replied, post #7 · Documentation › Doc review · 3 Apr 2025 · 0 likes post #6 answers the question as asked. The question underneath it is different. Multilingual versions: if a maintained page should exist in another language, suggesting…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #91 · Compounds › Cagrilintide & amylin analogues · 2 Apr 2025 · 0 likes post #90 answers the question as asked. The question underneath it is different. Cagrilintide alone is discussed less than in combination because the published data is…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #72 · Compounds › Cagrilintide & amylin analogues · 31 Mar 2025 · 5 likes Coming back to post #70, because the follow-up matters more than the original answer. For anyone arriving from searches on "amylin agonist": this subcategory discusses…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #84 · Analytics › COA interpretation · 15 Mar 2025 · 0 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #101 · Pharmacology › Receptor biology · 15 Mar 2025 · 17 likes Species differences: rodent studies show the same compounds produce effects in rodents that predict human effects reasonably well for semaglutide and tirzepatide. The…
-
Follow-up: Journal club: the retatrutide phase 2 obesity paper Replied, post #3 · Evidence › Journal club · 14 Mar 2025 · 9 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Assessing a warm arrival: the decision process Replied, post #12 · Sourcing › Logistics · 11 Mar 2025 · 17 likes Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…
-
Severe gastroparesis and why this class is a poor fit Started this topic · Safety › Contraindications · 7 Mar 2025 · 58 likes On the subject in the title: Severe gastroparesis and why this class is a poor fit Working notes rather than a conclusion. Asking about a population rather than about a…
-
Validating a method you did not develop — does this still hold? Replied, post #30 · Analytics › Method validation · 21 Feb 2025 · 17 likes post #29 is right about the mechanism and I think understates the practical bit. Why two laboratories may disagree: after validating the same method, they may still…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #60 · Compounds › Cagrilintide & amylin analogues · 3 Feb 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Canadian access and provincial variation Replied, post #46 · Regional › North America · 2 Feb 2025 · 2 likes Worth separating two things that post #42 runs together. Regional variation in North America: access differs substantially by US state and Canadian province. Postcode…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #97 · Compounds › Semaglutide · 1 Feb 2025 · 0 likes Worth separating two things that post #93 runs together. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation…
-
A vial that will not fully dissolve: what to check and in what order Replied, post #10 · Practice › Reconstitution · 23 Jan 2025 · 30 likes Picking up post #7: that is the part I would want checked first. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL…
-
[2026 update] New subcategory: rationale and scope Replied, post #143 · Meta › Announcements · 12 Jan 2025 · 29 likes post #142 is right about the mechanism and I think understates the practical bit. Implementation timeline: announcements include when a change takes effect. Marking the…
-
Specification in the result column: why that is a meaningful error — the long version Replied, post #7 · Analytics › COA interpretation · 9 Jan 2025 · 12 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
-
Gallbladder disease risk with rapid weight loss Replied, post #53 · Clinical › Comorbidities · 5 Jan 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Persistent vomiting and the threshold for seeking help — one year on Replied, post #34 · Safety › Adverse events · 22 Dec 2024 · 0 likes Allergic reactions: true allergy (anaphylaxis, severe rash) is rare with these peptide compounds but possible. Distinguishing true allergy from GI intolerance matters.
-
Building a sensible monitoring schedule with your prescriber Replied, post #54 · Clinical › Bloodwork · 20 Dec 2024 · 5 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
-
What we do not know about retatrutide, listed explicitly Replied, post #27 · Compounds › Retatrutide · 20 Dec 2024 · 1 like Dose escalation in the published trials: the protocols started at lower doses and escalated by defined steps. The step sizes are documented and they may or may not…
-
A page that has drifted out of date and needs a maintainer Replied, post #41 · Documentation › Wiki requests · 19 Dec 2024 · 23 likes Picking up post #38: that is the part I would want checked first. Authority and authorship: if you think a maintained page needs input from someone with specific…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #13 · Evidence › Journal club · 14 Dec 2024 · 17 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Transit times by route, from a logged dataset — the long version Replied, post #36 · Sourcing › Logistics · 6 Dec 2024 · 30 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #114 · Practice › Dosing & titration · 28 Nov 2024 · 1 like Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
Revisiting: Holding a dose indefinitely: is there a documented downside? Replied, post #11 · Practice › Dosing & titration · 26 Nov 2024 · 3 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #19 · Sourcing › Red flags · 25 Nov 2024 · 0 likes Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact repeatedly in short time windows raises suspicion about stability and…
-
What a well-designed human trial of a secretagogue would look like Replied, post #2 · Compounds › Secretagogues & GH axis · 20 Nov 2024 · 1 like the opening post is right about the mechanism and I think understates the practical bit. GHRH analogues versus ghrelin mimetics are often conflated but they are…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #54 · Compounds › Repair & healing peptides · 14 Nov 2024 · 31 likes Picking up post #51: that is the part I would want checked first. Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5 Da). Identity…
-
Revisiting: Moderation log format change Replied, post #5 · Meta › Announcements · 23 Oct 2024 · 32 likes Worth separating two things that the opening post runs together. Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #12 · Clinical › Bloodwork · 6 Sep 2024 · 32 likes Coming back to post #10, because the follow-up matters more than the original answer. Renal function markers: eGFR is estimated, not measured. It depends on creatinine,…
-
Follow-up: Oral contraceptives and delayed emptying: what the data shows Replied, post #13 · Practice › Interactions · 3 Sep 2024 · 12 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
Correlation in a self-tracked dataset: what it can support Replied, post #54 · Research Methods › Statistics · 22 Aug 2024 · 19 likes On post #50 — agreed on the reasoning, with one qualification. Effect sizes: the magnitude of a difference, not just whether it is statistically significant. A…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #18 · Analytics › COA interpretation · 9 Aug 2024 · 0 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #2 · Compounds › Retatrutide · 15 Jul 2024 · 12 likes Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is where that question gets answered. Using phase 2 results to make…
-
Cold packs, phase-change material, and what survives ten days Replied, post #30 · Sourcing › Logistics · 21 Jun 2024 · 0 likes Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a handling problem in transit. The contents may or may not be…
-
Follow-up: A partial dose because the pen emptied mid-injection Replied, post #2 · Practice › Administration · 18 Jun 2024 · 3 likes On the opening post — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…